Stock Screener App

Frei -

Installieren

5.27

2.23% -0.12

after-market

Handel nachbörslich: 5.30 0.03 +0.57%

Immuneering Corp (IMRX)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Immuneering Corp-Aktie (IMRX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	10.58% 13.75	15.38	-	15.48	18.56
Operating Income/Loss	10.58% -13.75	-15.38	-	-15.48	-18.56
Income/Loss From Continuing Operations Before Tax	22.62% -11.58	-14.96	-14.43	-15.05	-18.05
Income/Loss From Continuing Operations After Tax	22.62% -11.58	-14.96	-14.43	-15.05	-18.05
Net Income/Loss	22.62% -11.58	-14.96	-14.43	-15.05	-18.05
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	82.52% 6.9348	39.67	-	35.53	0.3589
Diluted Average Shares	82.52% 6.9348	39.67	-	35.53	0.3589
Basic Earnings Per Share	81.58% -0.07	-0.38	-	-0.42	-0.59
Diluted Earnings Per Share	81.58% -0.07	-0.38	-	-0.42	-0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ROIV

$29.66

0.98%

BNTX

$92.25

0.12%

INSM

$108.87

2.48%

RPRX

$53.86

1.17%

ONC

$302.44

2.52%

RVMD

$154.89

2.20%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters